Clinical Trial Update: YN001-004 in Patients With Coronary Atherosclerosis in Australia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for YN001-004 in patients with coronary artery disease/atherosclerotic disease is currently recruiting in Australia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Atherosclerotic Disease

Snippet

Sponsor: Beijing Inno Medicine Co., Ltd. | Conditions: Coronary Artery Disease, Coronary Atherosclerotic Disease | Phase 2 | Status: RECRUITING